Filip Meersman
- Biomaterials top 2%
- Biotechnology top 2%
- Microbial Inactivation Methods 8
- Molecular Biology top 5%
- Protein Structure and Dynamics 36
- Prion Diseases and Protein Misfolding 7
- Molecular Medicine top 5%
- Food Science top 2%
- Proteins in Food Systems 12
-
- Enzyme Structure and Function 20
-
- Spectroscopy and Quantum Chemical Studies 6
-
- Hemoglobin structure and function 6
-
- Alzheimer's disease research and treatments 5
- Co-authors
- Karel HeremansChristopher M. DobsonLászló SmellerPaul F. McMillanThierry AstrucAnne DuconseilleVéronique Santé-LhoutellierAndré Matagne
- Partner nations
- BelgiumUnited KingdomHungary
In The Last Decade
Filip Meersman
80 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Biomaterials 490
- Biotechnology 321
- Molecular Biology 1.9k
- Molecular Medicine 138
- Food Science 336
Countries citing papers authored by Filip Meersman
This map shows the geographic impact of Filip Meersman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Meersman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Meersman more than expected).
Fields of papers citing papers by Filip Meersman
This network shows the impact of papers produced by Filip Meersman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Meersman. The network helps show where Filip Meersman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Filip Meersman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2019 | 12 | |
| 3 | 2019 | 233 | |
| 4 | 2014 | 14 | |
| 5 | 2013 | 14 | |
| 6 | 2011 | 19 | |
| 7 | 2011 | 57 | |
| 8 | 2011 | 20 | |
| 9 | 2010 | 48 | |
| 10 | 2010 | 11 | |
| 11 | 2008 | 13 | |
| 12 | 2008 | 16 | |
| 13 | 2007 | 17 | |
| 14 | 2006 | 28 | |
| 15 | 2006 | 52 | |
| 16 | 2005 | 141 | |
| 17 | 2005 | 92 | |
| 18 | 2005 | 78 | |
| 19 | 2002 | 41 | |
| 20 | 2002 | 18 |
About Filip Meersman
Filip Meersman is a scholar working on Biotechnology, Biophysics and Physical and Theoretical Chemistry, having authored 82 papers that have together received 3.9k indexed citations. Recurring topics across this work include Protein Structure and Dynamics (36 papers), Enzyme Structure and Function (20 papers), Proteins in Food Systems (12 papers), Microbial Inactivation Methods (8 papers), Prion Diseases and Protein Misfolding (7 papers), Spectroscopy and Quantum Chemical Studies (6 papers), Hemoglobin structure and function (6 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Biomaterials (490 citations), Biotechnology (321 citations) and Molecular Biology (1.9k citations). Filip Meersman has collaborated with scholars based in Belgium, United Kingdom and Hungary. Frequent co-authors include Karel Heremans, Christopher M. Dobson, László Smeller, Paul F. McMillan, Thierry Astruc, Anne Duconseille, Véronique Santé-Lhoutellier, André Matagne, Yuqing Wu and Mireille Dumoulin. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.